SCHEMBL4150810

SCHEMBL4150810

Nc1ccc2n[c]oc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
KMT2A Q03164 6/20 0.42
MAPT P10636 5/20 0.42
MEN1 O00255 5/20 0.42
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
HPGD P15428 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
PTPN11 Q06124 1/20 0.38
DYRK1A Q13627 1/20 0.38
PLAU P00749 1/20 0.36
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
F2 P00734 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4152683 0.83 RAB9A (0.42) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL207175 0.75 BACE1 (0.34) KMT2AMEN1ALDH1A1HTT
SCHEMBL207905 0.75 PIK3CG (0.44) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL939151 0.75 KDM4E (0.43) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL533256 0.71 ALDH1A1 (0.43) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL11784333 0.71 SCN10A (0.36) KMT2AMAPTMEN1ALDH1A1SMN1; SMN2
SCHEMBL5708068 0.69 NPC1 (0.35) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL11786390 0.67 KMT2A (0.45) KDM4EKMT2AMAPTMEN1ALDH1A1
SCHEMBL4964901 0.67 TYMS (0.35) MAOASLC6A4
SCHEMBL3746355 0.67 NQO2 (0.43) KDM4EMAPTALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds CORFIELD JOHN ANDREW 2009-05-28 US claimed
WO-2009000818-A1 3-CARBONYLAMINOTHIOPHENE-2-CARBOXYLIC ACIDS AS HEPATITIS C VIRUS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-31 WO claimed
EP-1971599-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SmithKline Beecham Corporation (US) 2008-09-24 EP claimed
WO-2007071434-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-06-28 WO claimed
CN-104204037-B Polyamic acid and containing its resin combination 东丽株式会社 2016-08-24 CN disclosed
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds CORFIELD JOHN ANDREW 2009-05-28 US disclosed
WO-2009000818-A1 3-CARBONYLAMINOTHIOPHENE-2-CARBOXYLIC ACIDS AS HEPATITIS C VIRUS INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-31 WO disclosed
EP-1971599-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SmithKline Beecham Corporation (US) 2008-09-24 EP disclosed
WO-2007071434-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136448-A1 Antiviral 2-Carboxy-Thiophene Compounds EIF2AK2, HAVCR2, MAVS KDM4E 794/4885KMT2A 3128/4885MAPT 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.